In the most recent fiscal period operating loss reflected progress to $-0.904193 millions, at the NUBI

Underlining the most recent fiscal period the Construction Services company recorded a deficit per stock at $-0.75 per share, relative to the recent numbers of $7.33 per share a year ago financial reporting period, In the prior financial reporting period the Stratus Properties Inc realized $-0.29 per share.

Stratus Properties Inc stock quotes, charts, profile

Stratus Properties Inc Revenue improvement Rates

An eye-catching deterioration in Revenues at the company amid the October to December 31 2022 interval

For the financial interval ending December 31 2022 company earnings turned positive of $0.01 per share compare to $-0.14 a year before and earnings per share dropped by -99.63 % from $1.64 per share from the preceding reporting season.

Revenues faded by -37.649 % to $0.19 millions from $0.31 millions in the similar reporting season a year before and sequentially Revenue Tumbled by -49.218 % from $0.38 millions.

Aei Income And Growth Fund Xxi Limited Partnership Competitors, Market Share

Aei Income And Growth Fund Xxi Limited Partnership Revenue elevation Rates

Shortfall Despite of Revenues growth at the CMCT during the fourth quarter of 2022 earnings season

For the fourth quarter of 2022 earnings season company Losses have widen of $-0.39 per share compare to $-0.38 a year before and earnings per share improved from $-0.50 per share from the preceding reporting period.

Revenue grew moderately by 2.957 % to $25.87 millions from $25.13 millions in the corresponding reporting period a year before and sequentially Revenues grew by 4.084 % from $24.85 millions.

Creative Media And Community Trust Corporation Competitors, Market Share

Creative Media And Community Trust Corporation Suppliers

Profitability not reached inspite of impressive Revenues at the company over the financial interval ending December 31 2022

For the fourth quarter of 2022 Aspira Women S Health Inc lost money of $-0.04 per share compare to $-0.08 a year before and from $-0.04 per share from the prior financial reporting period.

Revenues rose substantially by 16.316 % to $2.15 millions from $1.85 millions in the same financial reporting period a year before and sequentially Revenues increased by 3.909 % from $2.07 millions.

Aspira Women S Health Inc Competitors, Market Share

Aspira Women S Health Inc Revenue advance Rates

The Regional Banks company disclosed a modest accomplishment, all along the most recent fiscal period

For the financial span closing December 31 2022 company income per share plummeted by -44.5 % of $0.55 per share compare to $0.99 a year prior and profit plummeted by -55.19 % from $1.22 per share from the prior financial reporting period.

Revenues depreciated by -6.343 % to $8.80 millions from $9.40 millions in the same financial reporting period a year prior and sequentially Revenues fell by -26.514 % from $11.98 millions.

Quaint Oak Bancorp Inc Suppliers

Quaint Oak Bancorp Inc Income Statement, Balance sheets, Cash Flow Statement

The company announced sudden contraction in Revenues, in the fiscal fourth quarter of 2022

In the most recent fiscal period Computer Hardware company announced soft top and bottom-line, where reached break-even and revenue by -15.427 % year on year. Revenue were to $5.17 millions in contrast to $6.11 millions eps at $0.00 compared to $0.09 in the same span a year before.

Socket Mobile Inc stock quotes, charts, profile

Socket Mobile Inc advance Rates, Profitability, PE

Among many businesses, the BTTX announced as well the fourth quarter of 2022 results

Trailing the large companies in the Medical Equipment & Supplies sector, a few overlooked businesses are reporting the results. BTTX told it has reported operating loss of $-8.322 millions, for the fourth quarter of 2022.

Better Therapeutics Inc Competitors, Market Share

Better Therapeutics Inc Suppliers

For the fourth quarter of 2022 earnings season company decreased a loss per share of $-0.84 per share compare to $-1.28 a year prior and earnings per share improved from $-1.50 per share from the prior reporting period.

Revenues remained unaltered to $0.00 millions from $3.67 millions in the comparable reporting period a year prior and sequentially Revenues surged from $0.00 millions.

Aptevo Therapeutics Inc Suppliers

Aptevo Therapeutics Inc Suppliers

Directing the awareness towards the October to December 31 2022 period Candel Therapeutics Inc Diminishing Returns have expanded at $-0.15 per share, relative to the recent numbers of $1.54 per share a year before reporting period, In the previous reporting period the Biotechnology & Pharmaceuticals company realized $-0.30 per share.

Candel Therapeutics Inc stock quotes, charts, profile

Candel Therapeutics Inc Income Statement, Balance sheets, Cash Flow Statement